Cargando…
SOX30 methylation correlates with disease progression in patients with chronic myeloid leukemia
BACKGROUND: Our previous study has reported that aberrant SOX30 methylation was associated with poor prognosis in AML, and it correlated with disease progression in MDS. Herein, we further determined SOX30 methylation and its clinical significance in the other myeloid malignance – chronic myeloid le...
Autores principales: | Zhang, Ting-Juan, Wen, Xiang-Mei, Zhou, Jing-Dong, Gu, Yu, Xu, Zi-Jun, Guo, Hong, Ma, Ji-Chun, Yuan, Qian, Chen, Qin, Lin, Jiang, Qian, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592060/ https://www.ncbi.nlm.nih.gov/pubmed/31417278 http://dx.doi.org/10.2147/OTT.S210168 |
Ejemplares similares
-
Identification and validation of SRY-box containing gene family member SOX30 methylation as a prognostic and predictive biomarker in myeloid malignancies
por: Zhou, Jing-dong, et al.
Publicado: (2018) -
Identification and validation of obesity-related gene LEP methylation as a prognostic indicator in patients with acute myeloid leukemia
por: Zhang, Ting-juan, et al.
Publicado: (2021) -
SLIT2 promoter hypermethylation predicts disease progression in chronic myeloid leukemia
por: Wu, De-long, et al.
Publicado: (2022) -
m6A regulator-based methylation modification patterns and characterization of tumor microenvironment in acute myeloid leukemia
por: Xu, Zi-Jun, et al.
Publicado: (2022) -
Abnormal expression and methylation of PRR34‐AS1 are associated with adverse outcomes in acute myeloid leukemia
por: Nan, Fang‐yu, et al.
Publicado: (2021)